Authorisation marks major step in European preparedness against ricin
Category: News
Data shows potential route to overcoming resistance in aggressive colorectal tumours
Partnership will analyse m6A RNA modifications in patient samples to support development of STC‑15
The first Excellence in Healthcare Partnerships (EHP) Awards and Networking Evening is afoot
New biologic option shown to reduce exacerbations and extend time to first flare
Sublingual apomorphine film offers rapid relief for OFF episodes
First‑in‑class SK ion channel inhibitor enters next stage of clinical development
Company aims to expand treatment options for relapsed or refractory multiple myeloma
Combination therapy moves into late‑stage testing after encouraging earlier results
Company prepares regulatory filings after treatment shows significant reduction in disease flare risk